IP Library Granted Patent US 10,231,813
Granted Patent B2
US 10,231,813 · App. 15/854,748 · Granted Mar 19, 2019

Porous devices and processes for producing same

Inventors: Wei-Hsang Chang (Duluth, GA); Stephen Lee Laffoon (Atlanta, GA); Christopher S. D. Lee (Atlanta, GA); David Lee Safranski (Atlanta, GA)
Assignee: Vertera, Inc.
A61F2/0077A61B6/12A61B6/50A61B90/39A61F2/44A61L27/18A61L27/50A61L27/56A61L31/06B29C44/0461B29C44/3415B29C67/202C08J9/0085C08J9/26A61B2090/3966A61F2002/0081A61F2002/0086A61F2210/0071A61F2250/0098A61L2430/38B29K2071/00B29L2031/753B29L2031/7546C08J2201/0446C08J2371/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,231,813
App. No.
15/854,748
Granted
Mar 19, 2019
Kind
B2
Abstract

A method for making a polymer with a porous layer from a solid piece of polymer is disclosed. In various embodiments, the method includes heating a surface of a solid piece of polymer to a processing temperature and holding the processing temperature while displacing a porogen layer through the surface of the polymer to create a matrix layer of the solid polymer body comprising the polymer and the porogen layer. In at least one embodiment, the method also includes removing at least a portion of the layer of porogen from the matrix layer to create a porous layer of the solid piece of polymer.

Claims (27)

1. A medical device for promoting tissue ingrowth, the medical device comprising a thermoplastic body defining a solid thermoplastic main body, a matrix layer, and a first porous surface layer, the first porous surface layer comprising a thermoplastic with a plurality of pores therein, each of the pores extending a defined distance from a first face into the first porous surface layer,

wherein the matrix layer comprises porogen particles surrounded by thermoplastic, and the matrix layer is positioned between the solid thermoplastic main body and the first porous surface layer.

2. The medical device of claim 1 , further comprising at least one marker for detecting the medical device on an x-ray.

3. The medical device of claim 2 , wherein the at least one marker comprises a radiolucent material.

4. The medical device of claim 3 , wherein the at least one marker further comprises a radiopaque material.

5. The medical device of claim 2 , wherein the at least one marker comprises a radiopaque metal.

6. The medical device of claim 5 , wherein the radiopaque metal is tantalum.

7. The medical device of claim 2 , wherein the at least one marker is substantially cylindrical, rectangular, triangular, or conical.

8. The medical device of claim 7 , where the at least one marker is substantially cylindrical.

9. The medical device of claim 8 , wherein the substantially cylindrical marker can be inserted into a portion of the thermoplastic body.

10. The medical device of claim 8 , wherein the substantially cylindrical maker can be inserted into a portion of the thermoplastic body and extends vertically through the thermoplastic body.

11. The medical device of claim 1 , wherein the thermoplastic body further defines a second porous surface layer formed from thermoplastic with a plurality of pores therein, each of the pores extending about the defined distance from a second face into the thermoplastic body.

12. The medical device of claim 11 , wherein:

the medical device further comprises at least one marker for detecting the medical device on x-ray; and

the at least one marker extends from the first face through the thermoplastic body to the second face.

13. The medical device of claim 12 , wherein the at least one marker is positioned so that it extends vertically through the medical device, and wherein end-surfaces of the marker are substantially flush with first and second faces of the thermoplastic body.

14. The medical device of claim 11 , wherein the defined distance is approximately 0.5 mm to 1.0 mm.

15. The medical device of claim 14 , wherein the defined distance is approximately 0.7 mm.

16. The medical device of claim 1 , wherein the solid thermoplastic main body comprises polyetheretherketone (PEEK).

17. The medical device of claim 1 , wherein:

the solid thermoplastic main body comprises a first particular percentage of hydroxyl groups; and

the first porous surface layer comprises a second particular percentage of hydroxyl groups, wherein the second particular percentage of hydroxyl groups is greater than the first particular percentage of hydroxyl groups.

18. The medical device of claim 1 , wherein:

the solid thermoplastic main body comprises a first particular carbon to oxygen atomic ratio; and

the first porous surface layer comprises a second particular carbon to oxygen atomic ratio, wherein the second particular carbon to oxygen atomic ratio is substantially the same as the first particular carbon to oxygen atomic ratio.

19. The medical device of claim 1 , wherein the expulsion resistance of the medical device is at least about 1.5 times greater than the expulsion resistance of a medical device of similar material, with no porous layers.

20. The medical device of claim 1 , wherein the first porous surface layer has a particular wettability, and wherein the particular wettability is greater than a wettability of the solid thermoplastic main body.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2022
From: CHANG, WEI-HSIANG
To: VERTERA, INC.
Reel/Frame 061923/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2022
From: VERTERA, INC.
To: NUVASIVE, INC.
Reel/Frame 061669/0954 →
SECURITY INTEREST Recorded Feb 28, 2020
From: NUVASIVE, INC.; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052918/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2018
From: CHANG, WEI-HSANG; LAFFOON, STEPHEN LEE; LEE, CHRISTOPHER S.D.; SAFRANSKI, DAVID LEE
To: VERTERA, INC.
Reel/Frame 047042/0141 →
Continuity (5)
Continuation 15362223 · Nov 28, 2016
Continuation 14752762 · Jun 26, 2015
Continuation In Part 14587856 · Dec 31, 2014
Provisional Application 62017834 · Jun 26, 2014
Related Publication 20180193126A1 · Jul 12, 2018
Cited By (1)
US 12,570,028